Nanjing Vazyme Biotech Co Ltd (688105) — Tangible Net Worth Ratio
Nanjing Vazyme Biotech Co Ltd (688105) has a Tangible Net Worth Ratio of 97.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥80.07 Million) from net assets (CN¥3.60 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Nanjing Vazyme Biotech Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Nanjing Vazyme Biotech Co Ltd Tangible Net Worth Ratio (2017–2025)
This chart shows how Nanjing Vazyme Biotech Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 97.8%, reflecting net assets of CN¥3.60 Billion with intangible assets of CN¥80.07 Million CNY. For live market cap and overall valuation, see 688105 stock market capitalisation.
Annual Tangible Net Worth Ratio for Nanjing Vazyme Biotech Co Ltd (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Nanjing Vazyme Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore how much does Nanjing Vazyme Biotech Co Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.7% | CN¥3.79 Billion | CN¥86.63 Million | CN¥5.03 Billion | ▲ +0.1 pp |
| 2024 | 97.6% | CN¥3.94 Billion | CN¥95.19 Million | CN¥5.05 Billion | ▲ +0.1 pp |
| 2023 | 97.5% | CN¥4.03 Billion | CN¥101.24 Million | CN¥5.75 Billion | ▼ -1.4 pp |
| 2022 | 98.9% | CN¥4.61 Billion | CN¥49.70 Million | CN¥6.01 Billion | ▼ -0.7 pp |
| 2021 | 99.6% | CN¥4.13 Billion | CN¥16.65 Million | CN¥4.61 Billion | ▲ +0.2 pp |
| 2020 | 99.4% | CN¥1.33 Billion | CN¥7.42 Million | CN¥1.61 Billion | ▲ +0.6 pp |
| 2019 | 98.9% | CN¥200.02 Million | CN¥2.29 Million | CN¥324.33 Million | ▼ -0.7 pp |
| 2018 | 99.6% | CN¥166.08 Million | CN¥690.73K | CN¥250.75 Million | ▲ +0.1 pp |
| 2017 | 99.5% | CN¥150.82 Million | CN¥723.54K | CN¥188.40 Million | — |